Apotex Health Corp's latest earnings report reveals a significant miss, raising questions about its growth trajectory.
In its recent earnings for the quarter ending June 30, 2026, Apotex Health Corp (APTX.TO) reported an earnings per share (EPS) of -0.19, which is much lower than the analyst estimate of -0.01. This disappointing result reflects a surprise percentage of -1800.0%, continuing a trend of missed expectations for the company.
Recent earnings trend
Advertisement
Apotex Health Corp
APTX.TO
APTX.TO
Apotex Health Corp
WealthAwesomeMarket cap
$7.54B
52W high
$40.11
52W low
$26.01
1W change
+2.34%
Analyst Price Targets
Based on analyst covering APTX · as of Sep 23, 2026
Wall Street analysts forecast APTX stock price to rise 22.9% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$41.37
+22.9% Upside
Previously C$41.23 on Sep 17, 2026
Current Price
C$33.65
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APTX's historical volatility
30-Day Vol
46.3%
Annualized
90-Day Vol
49.6%
Annualized
Trend (90d)
+0.5%
Annualized drift
90d Mean
C$33.71
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$33.67 | C$28.70 – C$39.50 |
| 60 trading days | C$33.69 | C$26.88 – C$42.23 |
| 90 trading days | C$33.71 | C$25.56 – C$44.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Analyst coverage: 10 analyst(s) cover this name; upcoming EPS consensus is available.
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-11 | — | 0.4100 | — |
| 2026-06-30 | 2026-08-12 | -0.1900 | -0.0100 | -1800.0% |
Advertisement
Investor takeaway: For Canadian investors, Apotex's substantial earnings miss highlights the volatility and unpredictability of the pharmaceutical sector, especially as the company navigates its recent IPO and ongoing market pressures.
Bull case
Despite the earnings miss, analysts maintain a bullish consensus rating for Apotex Health Corp, with an average target price of C$41.24. This suggests there could be potential upside from its current trading levels. The company's recent IPO and market presence might set the stage for future growth.
Bear case
The significant earnings miss raises concerns about Apotex's operational efficiency and its ability to manage costs effectively. Investors may need to rethink their positions if the company doesn't show improved financial performance in the upcoming quarters.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
